Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Platelets provide a bounty of potential targets for therapy in multiple sclerosis.
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Discovery of peptoid ligands for anti-aquaporin 4 antibodies.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Physiotherapy as an immunoactive therapy? A pilot study.
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Symptom overlap in anxiety and multiple sclerosis.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis.]
Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Role of statins in the treatment of multiple sclerosis.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Pages
« first
‹ previous
…
134
135
136
137
138
139
140
141
142
…
next ›
last »